M&G Investment Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	$9.72M	Buy	73,615 +5,781	+9%	+$763K	0.03%	211
2023 Q3	$7.67M	Buy	67,834 +5,873	+9%	+$664K	0.03%	225
2023 Q2	$5.82M	Buy	61,961 +1,928	+3%	+$181K	0.02%	272
2023 Q1	$6.06M	Buy	+60,033	New	+$6.06M	0.03%	231